Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Climacteric : the Journal of the International Menopause Society
|
November 7, 2002
Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women
H Rozenbaum, O Chevallier, M Moyal, et al.
Clinical Therapeutics
|
October 27, 2010
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations
Stefan Vegter, Mark H Rozenbaum, Roelien Postema, et al.
The American Journal of Gastroenterology
|
April 1, 1987
Immune basis for cimetidine-induced pancytopenia
A Nagler, H Rozenbaum, R Enat, et al.
Epidemiology and Infection
|
November 26, 2011
Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
M H Rozenbaum, R De Vries, H H LE, et al.
Expert Review of Vaccines
|
December 21, 2012
Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around
Mark H Rozenbaum, Elisabetta De Cao, Tjalke A Westra, et al.
Vaccines
|
November 26, 2024
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
Aleksandar Ilic, Maria J Tort, Alejandro Cane, et al.
Vaccine
|
February 26, 2026
A comparative analysis of pediatric pneumococcal vaccination strategies: a dynamic model of PCV20 vs. PCV15 and PCV13
Michele Wilson, Benjamin M Althouse, Aaron Lucas, et al.
Clinical Therapeutics
|
August 24, 2010
Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands
Mark H Rozenbaum, Eelko Hak, Tjip S van der Werf, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2022
The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data
Marcel H Schöttler, Friso B Coerts, Maarten J Postma, et al.
Infectious Diseases and Therapy
|
January 27, 2023
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
Mark H Rozenbaum, Jen Judy, Diana Tran, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Climacteric : the Journal of the International Menopause Society
|
November 7, 2002
Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women
H Rozenbaum, O Chevallier, M Moyal, et al.
Clinical Therapeutics
|
October 27, 2010
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations
Stefan Vegter, Mark H Rozenbaum, Roelien Postema, et al.
The American Journal of Gastroenterology
|
April 1, 1987
Immune basis for cimetidine-induced pancytopenia
A Nagler, H Rozenbaum, R Enat, et al.
Epidemiology and Infection
|
November 26, 2011
Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
M H Rozenbaum, R De Vries, H H LE, et al.
Expert Review of Vaccines
|
December 21, 2012
Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around
Mark H Rozenbaum, Elisabetta De Cao, Tjalke A Westra, et al.
Vaccines
|
November 26, 2024
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
Aleksandar Ilic, Maria J Tort, Alejandro Cane, et al.
Vaccine
|
February 26, 2026
A comparative analysis of pediatric pneumococcal vaccination strategies: a dynamic model of PCV20 vs. PCV15 and PCV13
Michele Wilson, Benjamin M Althouse, Aaron Lucas, et al.
Clinical Therapeutics
|
August 24, 2010
Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands
Mark H Rozenbaum, Eelko Hak, Tjip S van der Werf, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2022
The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data
Marcel H Schöttler, Friso B Coerts, Maarten J Postma, et al.
Infectious Diseases and Therapy
|
January 27, 2023
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
Mark H Rozenbaum, Jen Judy, Diana Tran, et al.
Page
of 8